Better Coronavirus Stock: CureVac vs. Moderna

Motley Fool

23 Aug 2020 0 shares 1 views

Motley Fool

Published 23 Aug 2020

Two promising biotechs with COVID-19 vaccine candidates in development. One of them is the more likely winner.

Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Which stock wins in a matchup between a coronavirus vaccine leader and a coronavirus jack-of-all-trades?

Motley Fool 27 Aug 2020

Since the start of the pandemic, American billionaires have been cleaning up. As more than 50 million Americans filed for..

Eurasia Review 16 Aug 2020